GMIM
ACHN

General Motors Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

General Motors Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,038
Closed -$160K – 1057
2014
Q4 		$160K Hold
13,038
– – 0.01% 862
2014
Q3 		$130K Hold
13,038
– – 0.01% 884
2014
Q2 		$99K Buy
+13,038
New +$52K 0.01% 918

Other funds holding ACHN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

General Motors Investment Management's ACHN Position: Q1 2015 in Review

General Motors Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2015, closing a stake of 13,038 shares — an estimated $160K sold.

General Motors Investment Management first reported a position in ACHN in Q2 2014 and held it in 3 quarters. The position peaked at $160K in Q4 2014. 173 funds tracked by Wall St. Rank hold ACHN as of Q1 2015.

  • General Motors Investment Management reported no remaining Achillion Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • General Motors Investment Management sold 13,038 Achillion Pharmaceuticals shares in Q1 2015, an estimated $160K.
  • General Motors Investment Management first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 3 quarters.
  • General Motors Investment Management's Achillion Pharmaceuticals position peaked at $160K in Q4 2014.
  • 173 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2015.

Based on General Motors Investment Management's 13F filing for Q1 2015, filed 6 May 2015.